These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


316 related items for PubMed ID: 16412824

  • 41. [Disturbances of mineral metabolism and vascular calcifications in dialysis patients (review)].
    Malberti F, Ravani P.
    G Ital Nefrol; 2004; 21(3):238-44. PubMed ID: 15285002
    [Abstract] [Full Text] [Related]

  • 42. Osteogenic regulation of vascular calcification: an early perspective.
    Vattikuti R, Towler DA.
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E686-96. PubMed ID: 15102615
    [Abstract] [Full Text] [Related]

  • 43. [Management of hyperphosphatemia in patients with chronic kidney disease].
    Savica V, Santoro D, Monardo P, Mallamace A, Bellinghieri G.
    G Ital Nefrol; 2009 May; 26 Suppl 46():58-61. PubMed ID: 19644820
    [Abstract] [Full Text] [Related]

  • 44. Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats.
    Kumata C, Mizobuchi M, Ogata H, Koiwa F, Kondo F, Kinugasa E, Akizawa T.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():18-22. PubMed ID: 21595847
    [Abstract] [Full Text] [Related]

  • 45. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease.
    McCullough PA, Agrawal V, Danielewicz E, Abela GS.
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1585-98. PubMed ID: 18667741
    [Abstract] [Full Text] [Related]

  • 46. [Chronic kidney disease (CKD) and bone. Vascular calcification in CKD].
    Yokoyama K.
    Clin Calcium; 2009 Apr; 19(4):552-8. PubMed ID: 19329835
    [Abstract] [Full Text] [Related]

  • 47. [Vascular calcification in chronic kidney disease].
    Cozzolino M, Missaglia E, Ortiz A, Bellasi A, Adragao T, Apostolous T, Vescovo G, Gallieni M.
    Recenti Prog Med; 2010 Nov; 101(11):442-52. PubMed ID: 21197764
    [Abstract] [Full Text] [Related]

  • 48. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K.
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [Abstract] [Full Text] [Related]

  • 49. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 50. Close association of vascular and valvular calcification and prognosis of patients on continuous ambulatory peritoneal dialysis.
    Gen S, Inoue T, Nodaira Y, Ikeda N, Kobayashi K, Watanabe Y, Kanno Y, Nakamoto H, Suzuki H.
    Adv Perit Dial; 2008 Nov; 24():60-4. PubMed ID: 18986003
    [Abstract] [Full Text] [Related]

  • 51. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease.
    Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, Pickett W.
    Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059
    [Abstract] [Full Text] [Related]

  • 52. Inflammation and vascular calcification.
    Moe SM, Chen NX.
    Blood Purif; 2005 Nov; 23(1):64-71. PubMed ID: 15627739
    [Abstract] [Full Text] [Related]

  • 53. [Can cardiovascular calcifications be prevented in chronic kidney disease?].
    Coen G, Manni M, Mantella D, Splendiani G.
    G Ital Nefrol; 2006 Nov; 23 Suppl 34():S21-5. PubMed ID: 16633990
    [Abstract] [Full Text] [Related]

  • 54. The role of magnesium binders in chronic kidney disease.
    Spiegel DM.
    Semin Dial; 2007 Nov; 20(4):333-6. PubMed ID: 17635824
    [Abstract] [Full Text] [Related]

  • 55. Association of disorders in mineral metabolism with progression of chronic kidney disease.
    Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):825-31. PubMed ID: 17699293
    [Abstract] [Full Text] [Related]

  • 56. [The challenge of hyperphosphatemia control in chronic kidney disease].
    Lorenzo Sellares V.
    Nefrologia; 2008 Jul; 28 Suppl 5():3-6. PubMed ID: 18847412
    [Abstract] [Full Text] [Related]

  • 57. Dysregulated mineral metabolism in children with chronic kidney disease.
    Shroff R.
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):233-40. PubMed ID: 21422924
    [Abstract] [Full Text] [Related]

  • 58. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY.
    Semin Dial; 2007 May; 20(2):134-8. PubMed ID: 17374087
    [Abstract] [Full Text] [Related]

  • 59. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J.
    Am J Nephrol; 2012 May; 35(1):31-9. PubMed ID: 22179063
    [Abstract] [Full Text] [Related]

  • 60. [Mechanism and therapy of vascular calcification].
    Hara S, Yokoyama K.
    Clin Calcium; 2004 May; 14(5):752-5. PubMed ID: 15577037
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.